Prenetics Global (PRE) Common Equity (2021 - 2025)

Prenetics Global (PRE) has 5 years of Common Equity data on file, last reported at $156.5 million in Q4 2025.

• Common Equity for Q4 2025 came in at $156.5 million, down 8.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $156.5 million (down 8.18% YoY), and the FY2025 annual result was $156.5 million, down 8.18% from the prior year.
• Common Equity retreated to $156.5 million in Q4 2025 per PRE's latest filing, from $161.2 million in the prior quarter.
• Over five years, Common Equity peaked at $237.1 million in Q4 2022 and troughed at -$400.8 million in Q4 2021.
• A 5-year average of $149.9 million and a median of $185.5 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2024: Common Equity soared 159.15% in 2022, then retreated 21.28% in 2024.
• A 5-year view of Common Equity shows it stood at -$400.8 million in 2021, then soared by 159.15% to $237.1 million in 2022, then slipped by 12.95% to $206.4 million in 2023, then slipped by 17.43% to $170.4 million in 2024, then slipped by 8.18% to $156.5 million in 2025.
• Business Quant data shows PRE's Common Equity at $156.5 million in Q4 2025, $161.2 million in Q3 2025, and $150.9 million in Q2 2025.